![Allen A. Fienberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Allen A. Fienberg
Corporate Officer/Principal bei ITI, Inc. (New York)
Aktive Positionen von Allen A. Fienberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ITI, Inc. (New York) | Corporate Officer/Principal | - | - |
Karriereverlauf von Allen A. Fienberg
Ehemalige bekannte Positionen von Allen A. Fienberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Intra-Cellular Therapies, Inc. /Old/
![]() Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Gründer | 17.03.2011 | 26.09.2013 |
Corporate Officer/Principal | 01.05.2002 | 26.09.2013 | |
The Rockefeller University | Corporate Officer/Principal | 01.01.2002 | 01.01.2002 |
INTRA-CELLULAR THERAPIES, INC. | Corporate Officer/Principal | 05.09.2013 | - |
Novartis Institute for Functional Genomics, Inc.
![]() Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.01.1999 | - |
Ausbildung von Allen A. Fienberg
Yale University | Doctorate Degree |
University of California, Berkeley | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Corporate Officer/Principal | 5 |
Founder | 1 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INTRA-CELLULAR THERAPIES, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Intra-Cellular Therapies, Inc. /Old/
![]() Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Health Technology |
Novartis Institute for Functional Genomics, Inc.
![]() Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Commercial Services |
ITI, Inc. (New York) |
- Börse
- Insiders
- Allen A. Fienberg
- Erfahrung